About CMP Scientific
CMP Scientific: Driving Innovation in CE-MS Technology
​
CMP Scientific is founded on a groundbreaking technology platform that seamlessly integrates capillary electrophoresis (CE) with mass spectrometry (MS) — a powerful combination that enables high-resolution separation and sensitive detection of charged biomolecules. Our mission is to transform complex analytical challenges into practical, efficient solutions through advanced CE-MS instrumentation and consumables.
​
At the core of our product portfolio is the EMASS-II CE-MS ion source, engineered for reliable, high-sensitivity electrospray ionization from CE. Complementing the EMASS-II system is our ECE-001 capillary electrophoresis unit, designed for precision, flexibility, and ease of integration with leading mass spectrometers. We also provide a full suite of CE-MS consumables, including high-performance separation capillaries, electrospray emitters, and application-specific reagent kits that support workflows across proteomics, metabolomics, biopharmaceutical analysis, and clinical research.
​
We are especially proud to introduce our latest technological breakthrough: the BioSummit™ CVA cIEF-MS platform — a next-generation solution for charge variant analysis (CVA) of therapeutic proteins. Combining capillary isoelectric focusing (cIEF) with mass spectrometry, this platform sets new benchmarks for precision, resolution, and robustness in the characterization of biopharmaceutical products, offering a powerful tool for quality control, comparability studies, and in-depth structural analysis.
​
At CMP Scientific, we are committed to advancing the frontiers of analytical science. By providing state-of-the-art CE-MS solutions, we aim to empower laboratories around the world to meet the growing demands of high-resolution, high-throughput, and high-confidence molecular analysis.
​
Discover how our technologies can support your research, development, and regulatory goals — and help drive your next analytical breakthrough.
Our Company
CMP Scientific specializes in the development of cutting-edge instrumentation and technologies for biological mass spectrometry, with core expertise spanning proteomics, biologics characterization, polysaccharide analysis, and metabolomics. Our proprietary EMASS-II CE-MS technology has earned wide recognition in the global analytical chemistry community for its precision, automation, and reliability.
​
Built on a foundation of innovation and technical excellence, CMP Scientific continues to expand the boundaries of mass spectrometry applications. Our CR3520 cIEF-MS system enables automated, high-resolution charge variant analysis for complex biotherapeutics such as monoclonal antibodies (mAbs), bispecific antibodies, fusion proteins, and ADCs—offering researchers a powerful tool for in-depth characterization.
​
In addition to advancing our product portfolio, we have established strategic R&D and marketing collaborations with leading mass spectrometry companies worldwide. These partnerships drive continuous improvement and ensure our technologies remain closely aligned with the evolving needs of the life sciences and pharmaceutical industries.
​
At CMP Scientific, we are committed to enabling next-generation analytical capabilities through scientific rigor, innovation, and collaboration.
Mission
At CMP Scientific, we are driven by a clear mission: to empower every biological mass spectrometry lab with our advanced capillary electrophoresis–mass spectrometry (CE-MS) technology. Each day, we wake up inspired to push the boundaries of what's possible in life sciences, biopharmaceutical development, and clinical research.
At the heart of our innovation is the EMASS-II CE-MS ion source—CMP Scientific’s flagship technology. This high-performance ion source seamlessly integrates capillary electrophoresis with mass spectrometry, enabling precise, automated, and high-resolution analysis of complex biological molecules. Trusted by researchers and analytical scientists around the world, the EMASS-II platform delivers unmatched sensitivity, reproducibility, and ease of use across a wide range of applications.
​
Whether it’s characterizing charge variants in monoclonal antibodies, profiling complex proteomes, or analyzing polysaccharides and metabolites, our CE-MS solutions are designed to meet the most demanding analytical challenges.
​
We believe that by making CE-MS more accessible, intuitive, and powerful, we can help accelerate innovation in biomedical research, therapeutic discovery, and precision medicine. That belief drives everything we do.
BioSummit CE-MS Platform
The BioSummit™ CVA is a next-generation cIEF-MS platform engineered to deliver exceptional performance, reliability, and user experience. Purpose-built for advanced charge variant analysis, it represents a significant leap forward in the field of biomolecular characterization.
​
Designed with seamless operation in mind, the BioSummit™ CVA combines cutting-edge automation with precision analytics—ensuring smooth, reproducible workflows even in the most demanding research and development environments. From intact mass analysis and subunit-level investigation to peptide mapping, the BioSummit™ CVA provides robust, high-resolution data you can trust.
​
Whether you're working in biopharmaceutical development, quality control, or advanced proteomics, BioSummit™ CVA empowers your lab with consistent, high-confidence results—enabling faster decision-making and deeper biological insight.
With the BioSummit™ CVA, CMP Scientific sets a new standard in cIEF-MS technology—helping you unlock the full potential of biomolecular analysis.
Research and Development
CMP Scientific: Advancing Discovery Through CE-MS Innovation
​
CMP Scientific has built a strong track record of collaboration with a diverse array of partners across the life sciences and analytical research community. Our collaborators include academic institutions, biopharmaceutical companies, clinical research organizations, and analytical instrumentation manufacturers. Together, we have worked on cutting-edge research projects and the development of next-generation technologies designed to push the boundaries of scientific discovery.
​
These collaborations are driven by a shared vision: to solve complex analytical challenges with more precise, efficient, and innovative tools. At the heart of our technology portfolio is our proprietary EMASS-II CE-MS system, a high-performance capillary electrophoresis-mass spectrometry platform designed to deliver unparalleled resolution, sensitivity, and data reproducibility.
​
Whether you're working in metabolomics, proteomics, drug development, biomarker discovery, or clinical diagnostics, the EMASS-II system offers a robust solution for applications where traditional analytical methods may fall short. Our technology enables:
​
-
High-efficiency separations of charged analytes, even in highly complex biological matrices
-
Exceptional data quality, allowing for accurate quantification and confident identification
-
Reliable performance and scalability for both research and regulated environments
-
Flexible integration into diverse workflows, whether for routine analysis or advanced method development
If you’re facing a challenging analytical problem or looking to enhance the performance of your current workflows, we encourage you to reach out. You may be surprised by how effectively CMP Scientific’s CE-MS technology can help you overcome technical barriers and accelerate your path to discovery.
​
Let’s explore how EMASS-II can empower your next breakthrough.